title: Dopamine D4 receptors regulate intracellular calcium concentration in cultured chicken cone photoreceptor cells: relationship to dopamine receptor-mediated inhibition of cAMP formation.
abstract: Dopamine is a retinal neuromodulator secreted from amacrine and interplexiform cells. Activation of dopamine D4 receptors on photoreceptor cells reduces a light-sensitive pool of cAMP. The aim of the present study was to evaluate the role of dopamine receptors and cAMP in the regulation of intracellular Ca(2+) concentrations ([Ca(2+)](i)) in photoreceptor cells of chick retina. Retinal cells from 6 day-old chicken embryos were isolated and cultured for 5-7 days prior to experiments. Cone photoreceptors were the predominant cell type in these cultures. Dopamine and agonists of dopamine D4 receptors suppressed K(+)-stimulated uptake of (45)Ca(2+) and [Ca(2+)](i), measured with the Ca(2+)-sensitive fluorescent dye fura-2AM. The effects of the agonists were blocked by dopamine D2/D4 receptor antagonists or by pertussis toxin. 8Br-cAMP, a cell-permeable analog of cAMP, had no effect on inhibition of K(+)-stimulated (45)Ca(2+) influx or [Ca(2+)](i) by dopamine D2/D4 receptor agonists. Quinpirole inhibited the increase in cAMP level elicited by K(+), which requires Ca(2+) influx through voltage-gated Ca(2+) channels, but not that induced by the calcium ionophore A23187. Moreover, dopamine had no effect on either forskolin-stimulated or Ca(2+)/calmodulin-stimulated adenylyl cyclase activity in cell membranes prepared from the cultured cells. These data indicate that the decrease of cAMP elicited by dopamine D4 receptor stimulation may be secondary to decreased [Ca(2+)](i).
authors: Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road NE, Atlanta, GA 30322, USA.
authors: Tamara N
authors: TN
authors: Ivanova
authors: Angel L
authors: AL
authors: Alonso-Gomez
authors: P Michael
authors: PM
authors: Iuvone
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D047068:Arylalkylamine N-Acetyltransferase / Q000378:metabolism; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D002642:Chick Embryo; D003024:Clozapine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D016257:Fura-2 / Q000031:analogs & derivatives / Q000378:metabolism; D018756:GABA Antagonists / Q000494:pharmacology; D007424:Intracellular Fluid / Q000187:drug effects / Q000378:metabolism*; D007476:Ionophores / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D050638:Receptors, Dopamine D4 / Q000502:physiology*; D012160:Retina / Q000166:cytology; D017949:Retinal Cone Photoreceptor Cells / Q000187:drug effects / Q000378:metabolism*; D013134:Spiperone / Q000494:pharmacology
chemical_list: D018492:Dopamine Antagonists; D018756:GABA Antagonists; D007476:Ionophores; C049925:fura-2-am; D050638:Receptors, Dopamine D4; C016276:8-bromocyclic GMP; D000001:Calcimycin; D013134:Spiperone; D000242:Cyclic AMP; C520223:Aanat protein, rat; D047068:Arylalkylamine N-Acetyltransferase; D006152:Cyclic GMP; D003024:Clozapine; D011188:Potassium; D002118:Calcium; D016257:Fura-2; D004298:Dopamine